Creesevita Subcutaneous Injection 30mg, which contains burosumab (genetical recombination), is a human monoclonal antibody manufactured by Kyowa Kirin. This medication is used to treat X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO), supplied as a 30mg 1mL 1 bottle with YJ code 3999452A3027.
Creesevita Subcutaneous Injection 30mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →